CD177 and osteosarcoma: These proteins not only facilitate oncogenic pathways initiated by activated cell surface receptors but are also overexpressed in various malignancies, such as glioma, osteosarcoma, cervical cancer, and nasopharyngeal carcinoma, where their presence correlates with poor prognosis [12, 21–23, 26].